Recommended

The Readout
The Readout March 21, 2025

Alnylam enters the ATTR-CM drug race

Biotech
Biotech March 20, 2025

STAT Plus: Alnylam drug wins FDA approval for progressive heart disease

By Elaine Chen

advertisement

Politics
Politics March 20, 2025

STAT Plus: Former FDA commissioner Scott Gottlieb questions RFK Jr.’s measles response, infant formula plan

Biotech
Biotech March 20, 2025

STAT Plus: A new biotech licensing Chinese drugs with a unique approach gets high-profile backing

Biotech
Biotech March 20, 2025

STAT Plus: Gene therapies and CRISPR drugs slowed by ‘irrational pessimism,’ say scientists forging new paths

By Eric Boodman and Katie Palmer

Subscriber Picks